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INTRODUCTION
Adipose tissue plays a central role in the management of systemic energy stores as well as in many other processes [1] . This is in part due to its capacity to store triglycerides but is also a function of its ability to secrete many bioactive adipocytokines that have a major impact on energy homeostasis and several other processes [1, 2] . Adiponectin, secreted exclusively by adipose tissue, is one of the most important metabolically active cytokine in relation to its function in cardiovascular system [2, 3, 4] . Adiponectin has attracted much attention because of its anti-diabetic, anti-Mankowska A., Sypniewska G., Rajewski P.,Gruszka M.
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atherogenic and anti-inflammatory effect [3, 5, 6] . Low-circulating levels of this adipokine are associated with multiple metabolic disorders including obesity, insulin resistance, type 2 diabetes, and cardiovascular disease [7, 8, 9, 10] . Furthermore adiponectin reduces oxidative stress and the release of C-reactive protein [11, 12] . It also influences on the process of atherogenesis reducing lipid accumulation in the blood vessels [13] . Recently, a few population-based studies presented results of adiponectin as a cardiovascular risk factor and its association with atherosclerosis, stable coronary artery disease and acute coronary syndromes [2, 7, 10, 14] . Little is known about the association of adiponectin and such cardiovascular risk factors such as blood pressure. We aimed to investigate the relationship between serum adiponectin and indices of cardiovascular risk in young women with excessive body mass.
SUBJECTS
The study group included 52 young women aged 20-40 yrs with abnormal body mass, recruited from patients of Department of Internal Diseases, E. Warminski City Hospital in Bydgoszcz. Study group consisted of 58 overweight and obese women (BMI≥ 25 kg/m2). The control group (BMI<25 kg/m2) consisted of 38 age-matched women (20-40 yrs) recruited on voluntary basis. Both groups were characterized by normoglycemia (< 100 mg/dL). We have accepted the following cut-off values for lipids and hsCRP : TC<200 mg/dL, HDL-C >50mg/dL, LDL-C<130mg/dL, TG<150 mg/dL, non-HDL-C <160 mg/dL, hsCRP <3mg/L. In each subject body weight and height were measured and BMI was calculated (kg/m 2 ); also blood pressure was examined. Women included into the study had not taken any contraceptives, antiinflammatory or other medicines known to affect lipid or carbohydrate metabolism. The written informed consent from each participant was obtained and the study was approved by the Bioethics Committee at Collegium Medicum, Nicolaus Copernicus University.
METHODS
Fasting blood was drawn in the early morning (7.00-9.00 am). Serum was obtained within less than 1 hour to avoid proteolysis and stored deep-frozen (-80°C) in small aliquots until assayed but not longer than 8 months.
Serum was assayed for HDL-cholesterol (HDL-C), triglycerides (TG), total cholesterol (TC), and glucose (ARCHITECT ci8200, Abbott Diagnostics). LDL-cholesterol (LDL-C) and non-HDL-C values were calculated. Serum CRP (hsCRP) concentration was measured by a high-sensitivity method (BN II, Dade Behring) and adiponectin was assayed by ELISA (DRG MedTek, R@D).
The height (cm), weight (kg) were measured using standard methods. Systolic and diastolic blood pressure (BP) were measured according to standard procedures by trained personnel. The cut-off value of systolic BP was <130 mmHg and <85mmHg for diastolic BP.
STATISTICAL METHODS
All data were presented as mean ± standard deviation (Gaussian distribution of results) or median and the 25 th and 75 th percentile (non-Gaussian distribution). The student t-test and U-Mann-Whitney test were used to compare differences. Comparison of mean values between groups were done by ANOVA or Kruskal-Wallis test. P<0,05 was considered statistically significant. Statistical analysis was performed using Statistica 8.0 for Windows (Stat Soft).
RESULTS
Characteristics of study and control groups is presented in Table 1 . Among measured biochemical parameters only median HDL-C and CRP concentrations were found to be below or over the accepted cut-offs. Median serum adiponectin in all women with excessive body mass (mean BMI 32,6 ±6,1 kg/m2) was significantly lower than in normal weight women, however this was especially observed in a subgroup of obese women (BMI 36,9±5,3; adiponectin 10,1 vs 15,5µg/mL; p<0.02). In overweight women (BMI 27,5±1,4) and controls adiponectin concentrations were similar.
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DISCUSSION
In the present study we have investigated whether adiponectin is related to cardiovascular risk in women with excessive body weight by analyzing the association of its serum level with biochemical and clinical variables. Hypoadiponectinemia in women with excessive BMI was found to be associated with significantly increased values of blood pressure and hsCRP concentration, that exceeded the accepted cut-offs.
Recent data suggest that adiponectin has many defensive properties against obesity-related hypertension [15, 16, 17] . Chow et al demonstrated for the first time an inverse relation between adiponectin concentration and the future development of hypertension [18] . They suggested that low adiponectin levels may play an important role in the pathogenesis of human hypertension. Low adiponectin levels are associated with increased plasma concentration of free-fatty acids and hepatic fat content and have been linked to the development of insulin resistance, which might, in turn, represent a base for the development of hypertension [19] . Hypoadiponectinemia might influence blood pressure also through other mechanisms, including endothelial dysfunction and the activation of the inflammatory cascade [18, 19] . Some studies suggested that adiponectin level measurements could be useful in identifying obese patients at high risk of dyslipidemia and cardiovascular disease [20] . Our results also confirm a close association of hypoadiponectinemia with increased cardiovascular risk related to hs-CRP level. Moreover, we may suggest that measuring adiponectin seems to offer additional value over hsCRP, used routinely as the inflammatory marker, in assessing cardiovascular risk in women with excessive body mass.
We are aware of the limitation of this study that includes a relatively small groups; however, our results suggest that adiponectin may be used as a prognostic marker of cardiovascular risk in women with excessive body mass.
